alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-Galp-yl group

Term ID

CHEBI:139279

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl
alpha-D-Gal-(1,3)-[alpha-L-Fuc-(1,2)]-beta-D-Gal-(1,3)-beta-D-GlcNAc-yl
alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->3)-beta-D-Gal-yl
alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->3)-beta-D-Gal-yl group
alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosyl
alpha-L-Fuc-(1->2)-[alpha-D-Gal-(1->3)]-beta-D-Gal-(1->3)-beta-D-Gal-yl
alpha-L-Fuc-(1->2)-[alpha-D-Gal-(1->3)]-beta-D-Gal-(1->3)-beta-D-Gal-yl group
alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl
alpha-L-fucosyl-(1->2)-[alpha-D-galactosyl-(1->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosyl
B-type 5 tetrasaccharide

Definition

A branched tetrasaccharide galactosyl group consisting of alpha-L-fucosyl and two beta-D-galactosyl residues linked sequentially (1->2) and (1->3), to the non-reducing-end galactosyl residue of which is also linked (1->3) an alpha-D-galactosyl residue. Blood group type-V B determinant.

References

PMID:28823097

Ontology

ChEBI ( EBI )

Relationships

is a type of: galactosyl group

galactosyl group Show first 5 Terms
has_role: epitope

epitope Show first 5 Terms
inverse has_part: alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-GalpO[CH2]6CH=CH2

alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-GalpO[CH2]6CH=CH2 Show first 5 Terms
is_substituent_group_from: alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-Galp

alpha-D-Galp-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-Galp Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-Galp-yl group

Phenotype where environments contain alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-Galp-yl group

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-Galp-yl group

Human Disease Model